Hearing loss in neonates and infants

Goun Choe1, Su-Kyoung Park2, Bong Jik Kim1

  • 1Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Korea.

Insights

Early detection and management of hearing loss in newborns and infants are vital for language development. Advances in screening, cochlear implants, and gene therapy offer promising future treatments for congenital hearing loss.

Area of Science:

  • Pediatrics
  • Audiology
  • Genetics

Background:

  • Congenital hearing loss is the most common sensory deficit in newborns, affecting 1.5 per 1,000 live births.
  • Genetic factors account for up to 80% of cases, with congenital cytomegalovirus being a key environmental cause.
  • Untreated hearing loss significantly impacts infant development and incurs socioeconomic burdens.

Purpose of the Study:

  • To highlight the critical importance of early hearing detection and intervention in neonates and infants.
  • To review current and emerging diagnostic and therapeutic strategies for congenital hearing loss.
  • To emphasize the role of advanced technologies in managing hearing impairments.

Main Methods:

  • Utilized automated auditory brainstem response and automated otoacoustic emission for newborn hearing screening.
  • Reviewed current auditory rehabilitation technologies, including advanced cochlear implantation.
  • Examined the progress in genetic diagnostic technologies and potential gene therapies.

Main Results:

  • Newborn hearing screening programs facilitate early detection and management of hearing loss.
  • Modern cochlear implantation effectively treats a wide range of hearing loss severities.
  • Genetic diagnostics and gene therapy represent promising future avenues for treatment.

Conclusions:

  • Early identification and intervention are crucial for optimal language and communication development in infants with hearing loss.
  • Technological advancements in diagnostics and treatment, particularly gene therapy, offer hope for improved outcomes.
  • A multidisciplinary approach combining screening, rehabilitation, and genetic insights is essential for managing congenital hearing loss.